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To an outsider, "sustainable agriculture" is a loose collection of aspirations
whose analytical content has yet to catch up to its considerable rhetorical force.
Proponents offer sustainability as the very "organizing theme" upon which other
agricultural policies should draw.' No standard definition of the concept has
emerged,2 but all rest on basic notions of balance between environmental and
economic factors. Some formulate this balance in its broadest social terms. For
example, according to the American Society of Agronomy, "[a] sustainable
agriculture is one that, over the long term, (1) enhances environmental quality and
the resource base on which agriculture depends, (2) provides for basic human
food and fiber needs, (3) is economically viable, and (4) enhances the quality of
life for farmers and society as a whole." 4
* Professor of Law, University of Iowa College of Law. E-mail: mark-janis@uiowa.edu.
1. According to Neil Hamilton, "the concept of sustainability is not a separate item in agricultural policy
debates over issues such as price, income support, and international trade. Instead, sustainability should be the
organizing theme upon which policies are based and the standard against which their performance is measured."
Neil D. Hamilton, The Role of Law in Promoting Sustainable Agriculture: Reflections on Ten Years of
Experience in the United States, 3 DRAKE J. AGRIC. L. 423, 430 (1998) [hereinafter Hamilton, Role of Law].
2. Indeed, the literature contains numerous apologies for the ambiguities that continue to surround the concept
of sustainability. See, e.g., Steve Padgitt & Peggy Petrzelka, Making Sustainable Agriculture the New
Conventional Agriculture: Social Change and Sustainability, in SUSTAINABLE AGRICULTURAL SYSTEMS 261,
268-69 (J.L. Hatfield & D.L. Karlen eds., 1994) ("Defining sustainable agriculture is elusive, and probably will
remain so.... One reason is the inevitable ambiguity that exists in the direction of any social movement"); Neil
D. Hamilton, Sustainable Agriculture: The Role of the Attorney, 20 ENVTL. L. REP. (Envtl. L. Inst.) 10021,
10022 (1990) ("A major hurdle in the debate over promoting sustainable agriculture is defining the term.").
3. See, e.g., Hamilton, Role of Law, supra note 1, at 425 ("Sustainable agriculture is defined in various ways,
but in its simplest form, it means developing agricultural practices which protect the environment while preserving
the economic profitability of farmers."); Neil D. Hamilton, Feeding our Future: Six Philosophical Issues Shaping
Agricultural Law, 72 NEB. L. REV. 210, 23940 (1993) (suggesting that sustainability might offer a conceptual
basis for a voluntary land ethic that might mollify environmentalists while protecting farm profitability).
4. David C. White et al., Economics of Sustainable Agriculture, in SUSTAINABLE AGRICULTURAL SYStmS
supra note 2, at 229, 232; see also Neil D. Hamilton, Agriculture Without Farmers? Is Industrialization
Restructuring American Food Production and Threatening the Future of Sustainable Agriculture?, 14 N. ILLU.
L. REV. 613, 645 (1994) (arguing that "[flor an agricultural production system to be sustainable it can not just deal
with soil and water or price and income, but the system must also consider the farmers, their families, and the rural
communities which make up the cultural structure of an agrarian system."). See generally MEETING THE
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Similarly, Gordon Conway has adeptly captured the exuberance of sustainable
agriculture while at the same time recognizing its weakness: "[a]lmost anything
that is perceived. as 'good' from the writer's perspective can fall under the
umbrella of sustainable agriculture: organic farming, the small family farm,
indigenous technical knowledge, biodiversity, integrated pest management, self-
sufficiency, recycling and so on."
5
Other, more humble definitions emphasize specific agricultural practices that
embody the aspirations of sustainability. For example, sustainable agriculture
might be defined in terms of practices such as crop diversification, biological-as
opposed to chemical--pest control, and "[g]enetic improvements in crops to
resist pests, diseases, and drought and to use nutrients more efficiently."6
Even the more constrained, agronomic definitions of sustainable agriculture
suggest an interconnection with intellectual property rights. Contemporary crop
genetic improvements derive largely from private investment in research and
development in both conventional breeding and plant biotechnology. Firms that
risk research and development dollars in plant innovation seek a wide array of
intellectual property rights in an effort to appropriate maximum returns on their
research and development investments.7 The availability and scope of intellectual
property protection for plant innovation may affect the level of private research
investment in plant innovation, and may affect the eventual level of user access to
the products and processes created in the course of such research. If the
creation and utilization of genetic crop improvements is an element of sustainable
EXPECTATIONS OF THE LAND: ESSAYS IN SUSTAINABLE AGRICULTURE AND STEWARDSHIP (Wes Jackson et al.
eds., 1984).
5. GORDON CONWAY, THE DOUBLY GREEN REVOLUTION: FOOD FOR ALL IN THE 21 ST CENTURY 163-64
(1997).
6. John Pesek, Historical Perspective, in SUSTAINABLE AGRICULTURAL SYSTEMS, supra note 2, at 1, 14.
Sustainable agriculture may be defined by "four broadly accepted elements:"
(1) prices which cover the full cost of production, including environmental costs and fair
income; (2) reduced dependence on chemical fertilizers and pesticides; (3) reduction of
externalind ecological impacts through pollution prevention and cost internalization; and
(4) greater reliance on the use of ecologically modem farming practices such as integrated
pest management (1PM), crop rotations, no-till and reduced tillage systems, and other
practices that reduce soil loss and contamination, cut air and water pollution, and avoid
losses in habitat and biodiversity.
Mark Ritchie & Kristin Dawkins, WTO Food and Agricultural Rules: Sustainable Agriculture and
the Human Right to Food, 9 MINN. J. GLOBAL TRADE 9, 21 (2000).
7. For an overview, see Jay P. Kesan, Intellectual Property Protection and Agricultural Biotechnology: A
Multidisciplinary Perspective, 44 AM. BEHAV. SCIENTIST 464 (2000). See also Debra L. Blair, Intellectual
Property Protection and its Impact on the U.S. Seed Industry, 4 DRAKE J. AGRIC. L. 297 (1999).
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agriculture, then the character of applicable intellectual property regimes is
necessarily also an element.
The role of intellectual property rights in agriculture has not escaped the
attention of policymakers in the agricultural arena. One prominent report warns
that "broad intellectual property claims, or claims on DNA sequences without a
true invention being made" have the capacity to stifle research and development in
plant genetics.8 Another study identifies "the nature and effect of broad patent
claims in agricultural biotechnology" as a major topic for future research. 9 Still
other studies place the issue in an international context.' 0
Undoubtedly, agricultural policy scholars will continue to seek out ways to
locate intellectual property rights within the framework of agricultural policy and,
specifically, the framework of sustainable agriculture. As an intellectual property
scholar, however, I am inclined towards taking a reverse perspective, asking how
the aspirations of sustainable agriculture might most plausibly find their collective
way into the modem intellectual property framework, with particular reference to
U.S. patent doctrine. In this essay, I explore two patent law doctrines and
analyze whether they are likely to prove effective as vehicles for sustainable
agriculture policy initiatives. I first consider the doctrine of subject matter
eligibility as applied to plant innovation. Here, I conclude that while proponents of
sustainable agriculture may be tempted to support efforts to impose restrictions
on patent eligibility for plant innovation, it is very doubtful that any such
restrictions would advance a policy agenda embodying sustainable agriculture
concepts. I next consider the doctrine of experimental use, a defense to patent
infringement-and, as such, a tool for shaping patent scope. I find the
experimental use doctrine to be more promising as a policy tool, but I counsel
against reliance on traditional judicial or legislative mechanisms for implementing
the doctrine, and propose an alternative approach.
8. ROYAL SOC' Y OF LONDON ET AL., TRANSGENIC PLANTS AND WORLD AGRICULTURE 34 (2000), awiab1e
at http://www.nap.edu/books/N1000227/html (published by the National Academies Press as the product of an
inter-academies working group).
9. William Lesser et al., Intellectual Property Rights, Agriculture, and the World Bank, in INTELLECTUAL
PROPERTY RIGHTS IN AGRICULTURE: THE WORLD BANK'S ROLE IN ASSISTING BORROWER AND MEMBER
COUNTRIES 1, 10 (Uma Lele et al. eds., 2000).
10. E.g., MAHENDRA SHAH & MAURICE STRONG, FOOD IN THE 21ST CENTURY: FROM SCIENCE TO
SUSTAINABLE AGRICULTURE 46-48 (2000) (describing the potential clash of interests between plant breeding firms
in the developed world that seek intellectual property rights to secure research and development investments and
farmers in the developing world who seek access to improved crop technology).
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I. PLANT INNOVATION AND RESTRICTIONS ON
PATENT-ELIGIBLE SUBJECT MATTER
The subject matter eligibility provision in U.S. utility patent law designates
four broad categories of patent-eligible subject matter: compositions, machines,
articles of manufacture, and processes." Plants are not expressly included; no
biological subject matter is included by express language. However, in 1980, the
Supreme Court construed section 101 to encompass genetically-modified
microorganisms. 2 In 1985, the United States Patent and Trademark Office
(PTO) applied the same rationale to extend section 101 to seed-grown plants.' 3
The PTO's construction remained unchallenged for several years. Recently,
the eligibility issue resurfaced in litigation between Pioneer Hi-Bred and an
independent farm supply dealer over the unauthorized sale of hybrid seed corn.
The Pioneer litigation focuses on the legal issue of whether the existence of an
additional form of intellectual property protection for plants (plant variety
protection under the Plant Variety Protection Act) signals Congress' intent to
exclude plants from the utility patent regime. 14 Both the district court and the
Court of Appeals for the Federal Circuit rebuffed the defendant dealer's challenge
to the propriety of the PTO's construction of section 101. 5 The case was on
review before the U.S. Supreme Court as of the time of this writing, and the
forthcoming opinion can be expected to concern itself primarily with this issue.
The more important policy issue, however, is whether eligibility restrictions can
serve as tools for effectuating agricultural policy initiatives. Specifically, should
proponents of sustainable agriculture expect that subject matter eligibility
restrictions would be an effective strategy for shaping the utility patent system to
respond to the aspirations of sustainable agriculture?6
11. 35 U.S.C. § 101 (1994).
12. See Diamond v. Chakrabarty, 447 U.S. 303, 314-18 (1980).
13. See Ex parte Hibberd, 227 U.S.P.Q. (BNA) 443 (Bd. Pat. App. & lnterf. 1985).
14. See infra pp. 110-15 for a more detailed explanation of plant variety protection.
15. Pioneer Hi-Bred Int'l, Inc. v. J.E.M. Ag Supply, Inc., 49 U.S.P.Q.2d (BNA) 1813 (N.D. Iowa Aug. 18,
1998), affd, 200 F.3d 1374 (Fed. Cir. 2000), cert. granted, No. 99-1996, 2001 U.S. LEXIS 1696 (Feb. 20,
2001). For relevant commentary on the Pioneer case, see Mark D. Janis & Jay P. Kesan, Weed-Free LP.: The
Supreme Court, Intellectual Property Interfaces, and the Problem of Plants, 70 U. CIN. L. REV (forthcoming
2001); Mark D. Janis & Jay P. Kesan, Designing an Optimal Intellectual Property System for Plants: A Supreme
Court Debatq 19 NATUREIBIOTECH. 981 (2001).
The Supreme Court has now affirmed. See Pioneer Hi-Bred Int'l, Inc. v. J.E.M. Ag Supply, Inc., 2001
WL 1560870 (Dec. 10, 2001).
16. Preliminarily, one might ask whether eligibility restrictions directed towards plant innovation would violate
international obligations. The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS),
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For two major reasons, restrictive patent eligibility rules make especially
clumsy policy instruments and should not be made the centerpiece of any effort
to inject sustainable agriculture values into the utility patent system. First,
experience has demonstrated that eligibility restrictions stimulate
counterproductive ancillary litigation over efforts by patent lawyers to draft
around the restrictions. Second, whereas policymakers may assume that
restricting utility patent eligibility forces innovation into the public domain, the fact
is that in some areas of technology---especially plant breeding-restricting utility
patent eligibility may simply divert innovation either to less socially desirable
intellectual property regimes or to other protection schemes.
A. Drafting Around Eligibility Restrictions
Rules restricting utility patent subject matter eligibility turn out to be clumsy
policy instruments. This clumsiness is attributable in part to the subtleties of
patent claiming practice.
Utility patents must include one or more claims defining the boundaries of the
patented invention. 17 There is no set format for,' 8 nor any required number of,
claims. Any given utility patent usually includes a number of claims that define
the invention in a variety of ways to maximize patent scope while distinguishing
the invention from prior art. The precise content of the claims depends in no
small part on the patent lawyer's drafting style and judgments about the
appropriateness of various claiming approaches.
which establishes international minimum standards for some substantive elements of patent law, is generally
antithetical to the use of subject matter eligibility restrictions to discriminate among technologies. See Agumi
on Trade-Related Aspects of Intellectual Property Rights [hereinafter TRIPS Agreement], Apr. 15, 1994, Marrakesh
Agreement Establishing the World Trade Organization, Annex IC, LEGAL INSTRUMENTS--RESULTS OFTHE
URUGUAY ROUND vol. 31, 33 I.L.M. 81, 94 (1994) ("patents shall be available and patent rights enjoyable
without discrimination as to... the field of technology .. "). However, the TRIPS Agreement makes a special
exception from the anti-discrimination principle for plants, authorizing member states to exclude from patent
eligibility "plants and animals other than micro-organisms, and essentially biological processes for the production
of plants or animals other than non-biological and microbiological processes. However, Members shall provide for
the protection of plant varieties either by patents or by an effective sui generis system or by any combination
thereof." Id. (further providing for a review of this provision after a specified time).
See infra notes 96-97 and accompanying text for a discussion of TRIPS Agreement provisions that might
affect an experimental use provision directed to plant innovation. See generally S.K. Verma, TRIPS and Plant
Variety Protection in Developing Countries, 17 EUR. INTELL. PROP. REv. 281 (1995) (discussing relevant TRIPS
articles against the backdrop of the International Convention for the Protection of New Varieties of Plants (UPOV)
and selected other regimes for plant protection).
17. 35 U.S.C. § 112 (1994).
18. Patent lawyers generally do comply with various drafting conventions that have evolved as a matter of
practice, but generally these concern matters of form.
2001]
INDIANA JOURNAL OF GLOBAL LEGAL STUDIES
Most of the rules in the utility patent system-including the eligibility rules-
are keyed t6 individual patent claims, not to patents as a whole. For example, a
hypothetical rule that "software" is not patent-eligible subject matter would, in
actual application, require the decisionmaker to analyze each independent claim in
a patent separately, determining whether that claim was directed to "software."
In any given patent, it is quite possible that some of the claims define patent-
eligible subject matter, while others do not.
Proponents of eligibility restrictions for utility patents on plants should pause
to consider how such restrictions would operate when applied to individual claims
to plant innovations. Consider, for example, a rule that "plants" are ineligible
subject matter.' 9 A superficial policy analysis might suggest that such a rule
would have major policy ramifications. For example, one can imagine arguments
that such restrictions would enhance farmer access to newly-developed crop
varieties.
The actual policy outcome would likely be quite different. To apply a "plant"
ineligibility rule, the courts or the PTO would need to determine whether
individual patent claims are drawn to a "plant" and thus fail to define patent-
eligible subject matter. Claims drawn expressly to plants will obviously fall within
the rule, but plant innovation may be claimed via a multiplicity of other
approaches. Consider the following examples:
(1) seed claim:
1. Inbred corn seed designated PHP38, having the ATCC
Accession No. 75612.20
(2) claim to other plant parts:
3. Pollen of the maize plant produced from seed of maize inbred
line designated PHKW3 and having ATCC Accession No.
97435.21
19. The Supreme Court has now held in Pioneer that the current statutory scheme does not require a plant
ineligibility rule. See Pioneer, 2001 WL 1560870, at *13. Of course, Congress might be asked to amend the
patent statute to incorporate such a rule.
20. U.S. Patent No. 5,506,367 (issued Apr. 9, 1996).
21. U.S. Patent No. 5,534,661 (issued July 9, 1996). Claim 3 of the patent is a dependent claim; I have
rewritten the claim for clarity, to incorporate the limitations of the underlying claims.
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(3) tissue culture claim:
3. A tissue culture of regenerable cells of a plant of the inbred
corn line PHKM5 and having ATCC Accession No. 97218
wherein the tissue regenerates plants having all of the
physiological and morphological characteristics of PHKM5. 2
2
(4) method claim:
7. A process to produce a hybrid corn seed which gives rise to
a hybrid corn plant having alleles which, when expressed,
contribute to hybrids which are adapted to the central corn belt
and which exhibit improvement in the traits of: yield, stay
green, stalks and roots, compared to similarly adapted hybrids,
comprising the steps of:
(a) planting, in pollinating proximity, seed of corn inbred
line PHN46 laving ATCC accession No. 91733 and
another inbred line, not PHN46;
(b) cultivating corn plants resulting from said planting, said
corn plants having a male and female reproductive
system;
(c) inactivating the male reproductive system prior to
pollination of the plants of either the female inbred line;
(d) allowing natural cross pollinating to occur between the
inbred lines; and
(e) harvesting seeds produced on said inactivated plants of
the inbred line.23
(5) product-by-process claim:
22. U.S. Patent No. 5,491,286 (issued Feb. 13, 1996). As in the preceding example, claim 3 of this ptmisa
dependent claim; I have rewritten the claim for clarity, to incorporate the limitations of the underlying claims.
23. U.S. Patent No. 5,567,861 (issued Oct. 22, 1996).
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8. F.sub. I hybrid corn seed produced by crossing the inbred
corn plant PHN46, having ATCC No. 91733, with another corn
plant that is not PHN46, and plants and parts thereof produced
from the F.sub.1 hybrid seed.24
It is not clear whether a rule restricting subject matter eligibility for "plants"
would render ineligible any of these example claims. Are plant parts "plants"?
Are breeding methods "plants"? And what of claims that are drawn to plants, but
crafted in terms of the methods used to breed them-so-called product-by-
process claims?
Unfortunately, a broad rule crafted merely to exclude "plants" from utility
patent eligibility resolves none of these questions definitively. In applying such a
rule, courts and the PTO would face uncomfortable choices. On the one hand,
extending the rule to claims that are directed to seeds, pollen, or other plant parts
calls for a considerable feat of interpretation. Extending the rule even further-
such as to method claims-under the guise of interpretation would seem
incongruous. On the other hand, limiting the rule to claims drawn expressly to
plants is also problematic, because the rule can be so easily circumvented-
simply by formulating claims to seeds or plant parts, for example-that it may be
rendered meaningless.
The preceding examples, of course, concern claims to plant innovation
resulting from conventional (non-biotech) breeding techniques. The dilemma is
even more intractable when the claimed invention concerns transgenic plants,
because biotechnology lends itself to an even wider array of potential claiming
formulations. For example, as an alternative to claiming the transgenic plant as
such, one might draft claims to the plant cell as genetically modified, 25 to the
plant DNA constituting the modification of interest, 26 or to a tremendous variety
of other genetic constructs ordinarily claimed as compositions. 27
24. Id.
25. For example, a patent relating to Calgene's infamous Flavr-Savr tomato includes claims to a genetically
modified plant cell. U.S. Patent No. 4,801,540 (issued Jan. 31, 1989) (stating in claim 14 "[a] tomato plant cell
comprising a DNA construct [having specified characteristics set forth in preceding claims]"). Claim 8caltfor"a
DNA sequence of at least 15 base pairs of a DNA sequence encoding tomato polygalacturonase (PG) joined, in the
opposite orientation for expression, 5' to the 3' terminus ofa transcriptional initiation region functional in plants."
Id.
26. Consider the following example relating to a tomato that has been genetically modified to exhibit Fuvarm
resistance:
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Ultimately, one must question whether a rule that generically excludes
"plants" from patent eligibility achieves socially desirable outcomes. Such a rule
is likely to give rise to gamesmanship in the semantics of claim drafting 28 and, as
a consequence, is likely to produce a swarm of ancillary litigation over
imponderables such as the true meaning of "plant." It seems very unlikely that
such a rule would be at all effective in accomplishing ambitious policy goals-
unless the goals include diverting resources to ancillary litigation. Indeed, rather
than stimulating the patent system to reflect ambitious policy objectives arising
from notions of sustainable agriculture, a generic exclusion of plants from patent
eligibility seems more likely to divert judicial and PTO resources towards
managing a confusion of rules on the scope of the exclusion.
These are not hypothetical debates. Each of the example claims (1) through
(5) set out above appears in patents that are in litigation in the Pioneer case at the
time of this writing.2 9 If Congress were to craft a broad "no plants" eligibility
restriction, it is very likely that disputes over claiming format, as just described,
would quickly arise at the PTO and in the courts.
Of course, it would be incorrect to suggest that a generic exclusion of all
"plants" from patent eligibility is the only cognizable eligibility restriction for plant
innovation. One could argue that even if there is little to be gained from an
apparently sweeping exclusion of all "plants" from the utility patent system, a
more focused eligibility restriction excluding claims to "plant varieties" might be
more palatable.30
I. An isolated DNA molecule which, when recombinantly transferred into a non-jute
tomato plant, expresses a protein which confers resistance to Fusarium oxysporum f.sp
lycopersici race 2, comprising:
(a) a DNA molecule comprising [a specified nucleotide sequence];
(b) a DNA molecule capable of hybridization with [the specified sequence under specified
conditions], and which encodes a protein which confers resistance to Fusarium
oxysporum f.sp lycopersici race 2; or
(c) a DNA molecule which encodes a protein encoded by the DNA of (a) or (b).
U.S. Patent No. 6,100,449 (issued Aug. 8, 2000).
27. For example, other claims in the Fusarium-resistant tomato patent are directed to gene constructs containing
the DNA, expression vectors, and so forth. Id.
28. On this phenomenon generally, see John R. Thomas, Of Text, Technique, and the Tangible: Drafting
Patent Claims Around Patent Rules, 17 J. MARSHALL J. COMPUTER & INFO. L. 219, 257 (1998) (exploring
strategies for drafting claims to circumvent eligibility restrictions).
29. See Pioneer, supra note 15.
30. Supporters of such an argument seem to start with the assumption that the protection afforded to plant
varieties under the Plant Variety Protection Act duplicates the protection that would be afforded under the utility
patent regime. For an explanation of the inaccuracy of this assumption, see infra notes 69-92 and accompanying
text.
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Whatever the apparent allure of such a restriction, however, the realities of
patent claiming practice would cast doubt on whether such a restriction is likely
to serve as an effective vehicle for policy change. To be sure, a claim directed
expressly to an individual plant variety would fail to define patent-eligible subject
matter under such a rule. Accordingly, the following claim, for example, would
surely be ruled invalid under such a regime: "1. A hybrid maize plant designated
3730 and its parts, representative seed capable of producing said hybrid maize
planting having ATCC accession number 209127.'
Nevertheless, a claim to a "plant"--that is, a broader claim that encompassed
many varieties without specifying any individual variety-would, in all likelihood,
survive. For example, it seems quite possible that the following claim to a
transgenic com plant, which is broad enough to cover many individual varieties,
would define patent-eligible subject matter under a "plant variety" restriction:
1. A fertile transgenic Zea mays plant comprising preselected
DNA encoding a seed storage protein, wherein the preselected
DNA is expressed so that the level of a seed storage protein
amino acid in said transgenic plant is increased above the level in
said plant not containing said preselected DNA, and wherein said
preselected DNA is heritable.3 2
Perhaps proponents of a "plant variety" restriction would be dubious about
the prospect of a court reaching this seemingly illogical outcome. In fact,
however, the example describes the current state of the law in Europe. Article
53(b) of the European Patent Convention currently excludes plant varieties from
utility patent protection:
European patents shall not be granted in respect of:
(b) plant or animal varieties or essentially biological processes
for the production of plants or animals; this provision does not
apply to microbiological processes or the products thereof.
33
31. U.S. Patent No. 5,689,036 (issued Nov. 18, 1997). This is another patent that is at issue in the Pioneer
litigation, which is discussed at supra note 15 and accompanying text.
32. U.S. Patent No. 6,160,208 (issued Dec. 12, 2000).
33. Convention on the Grant of European Patents, Munich, Oct. 5, 1973, reprinted in GERALDPATIERSTE
EUROPEAN PATENT SYSTEM 523-24 (1992). In addition to the European patent regime, another principal regime
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Applying article 53(b) to modem biotechnological inventions has proven a
monumental task for the European Patent Office.34 While the state of the law as
to some types of biotechnological inventions remains unclear, the European Patent
Office has now spoken definitively as to the application of article 53(b) to plant
innovation. In Novartis, the Enlarged Board of the European Patent Office ruled
that:
[A]ccording to Article 53(b) EPC, a patent is "in respect of plant
varieties" and shall not be granted if the claimed subject-matter
is directed to plant varieties. In the absence of the identification
of a specific plant variety in a product claim, the subject-matter
of the claimed invention is not directed to a plant variety or
varieties within the meaning of Article 53(b) EPC. That is why
it is... in agreement with the rules of logic that a patent shall
not be granted for a single plant variety but can be granted if
varieties may fall within the scope of its claims.35
The outcome of the eligibility debate in Europe reinforces the point that
eligibility restrictions designed to eject "plant varieties" from the utility patent
system will do nothing to address perceived problems of claim overbreadth.
Such restrictions cannot be relied upon as the centerpiece of a sustainable
agriculture-based reform agenda for the U.S. patent system.
Intellectual property scholars may find that the picture painted here-broadly-
drawn eligibility restrictions, extensive efforts to draft around the restrictions via
particular claim formats, and resultant counterproductive litigation-has an oddly
familiar aspect. It should. The U.S. patent system occupied itself for at least
three decades with the question of whether computer software inventions should
for the protection of plant innovation in Europe is the Community-wide system of plant variety protection.
Concerning the latter, see generally P.A.C.E. VAN DER KoOi, INTRODUCTION TO THE EC REGULATiONONPLANT
VARIETY PROTECTION (1997).
34. The celebrated-and seemingly endless-Harvard Onco-mouse decision exemplifies the difficulties. SwT
19/90, HarvardOnco-mouse, [1990] E.P.O.R. 501 (Tech. Bd. App.).
35. G 01/98, Novartis II/Transgenic Plant, [2000] E.P.O.R. 303, 319. The Novartis decision superseded the
previous authoritative statement on the issue from the Plant Genetic Systems decision of a Technical Board of
Appeal of the European Patent Office. See T 356/93, Plant Genetic Systems/Glutamine Synthetase Inhibitors,
[1995] E.P.O.R. 357 (Tech. Bd. App.) (disallowing a claim because it encompassed plant varieties even though it
was not drafted in terms of a specific plant variety as such). See generally Joshua V. Funder, Rethinking Patents
for Plant Innovation, 21 EuR. INTELL. PROP. REV. 551 (1999).
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qualify as patent-eligible subject matter.3 6 One concern that informed early
jurisprudence was that a patent claim directed to disembodied software--
disembodied, that is, from any particular computer or physical process-was a
claim to an "abstract idea."3 7 Responding to this concern, the Supreme Court
ruled in 1972 that patent claims defined ineligible subject matter if they wholly
preempted a mathematical algorithm.38 There followed several years of judicial
and PTO hand-wringing over the true nature of a "mathematical algorithm,"
producing a convoluted tangle of highly formalistic eligibility rules. 39 Eventually,
the Court of Appeals for the Federal Circuit all but abandoned the exercise in State
Street Bank, holding that software claimed in terms of a programmed computer
that produces specified "useful, concrete, and tangible result[s]" defines patent-
eligible subject matter.40
Recent experience with software-related inventions should inform any current
debate over patent eligibility restrictions for plants. The lesson from the software
area is quite clear: eligibility restrictions have the potential to work great chaos,
but lack demonstrated ability to force major policy reform.
36. The literature on the patent eligibility of software and business method inventions has become gigantic, and
the evolution of the relevant law has been recounted many times over. Within this tidal wave of scholarly
production are a few particularly adept summaries of the law. See, eg., John R. Thomas, The Patenting of the
Liberal Professions, 40 B.C. L. REV. 1139, 1148-63 (1999); Pamela Samuelson et al., A Manifesto Concerning
the Legal Protection of Computer Programs, 94 COLUM. L. REV. 2308 (1994); Richard H. Stem, Talesfmom the
Algorithm War: Benson to lwahashi, It's Deja Vu All Over Again, 18 AIPLA Q.J. 371 (1990).
37. Another concern was that granting patent protection to software would be cumulative in view of the
availability of copyright protection. This view is remarkably similar to the view that utility patent protection for
plants and plant variety protection are cumulative. See infra notes 69-92 and accompanying text (discussing
differences between the utility patent and plant variety protection regimes).
38. Gottschalk v. Benson, 409 U.S. 63 (1972). In its famous "nutshell," the Court held that:
It is conceded that one may not patent an idea. But in practical effect that would be the
result if the formula for converting BCD [binary-coded decimal] numerals to pure binary
numerals [the nature of the invention before the Court) were patented in this case. The
mathematical formula involved here has no substantial practical application except in
connection with a digital computer, which means that if the judgment below [allowing
eligibility] is affirmed, the patent would wholly pre-empt the mathematical formula and in
practical effect would be a patent on the algorithm itself.
Id. at 71-72.
39. A few notable decisions along the way include Diamond v. Diehr, 450 U.S. 175 (1981) (claims to a
computer-controlled process defined patent-eligible subject matter); Arrhythmia Research Tech., Inc. v. Corazonix
Corp., 958 F.2d 1053 (Fed. Cir. 1992) (claims to a software-implemented method defined patent-eligible subject
matter); In re Alappat, 33 F.3d 1526 (Fed. Cir. 1994) (en banc) (claims to software, drawn in terms of a
programmed general-purpose computer, defined patent-eligible subject matter).
40. State Street Bank & Trust Co. v. Signature Fin. Group, Inc., 149 F.3d 1368, 1373 (Fed. Cir. 1998), tat
denied, 119 S.Ct. 851 (1999). State Street is also well known for its refusal to countenance a special subject matter
exclusion for "business method[s]." Id. at 1375. The Supreme Court has not spoken on State Street's approach
either to software-related inventions generally or to business method inventions particularly.
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B. Diverting Plant Innovation to Less Desirable Protection Schemes
The preceding analysis offers a pragmatic perspective on the likely fate of
eligibility restrictions when those restrictions are articulated in fairly
straightforward ways: proscriptions against eligibility for "plants" or,
alternatively, for "plant varieties." But what of addressing the problem in
theoretical terms? That is, what if one assumes (contrary to experience) that the
courts or Congress could fashion an ideal eligibility standard that would resist
efforts at circumvention by claim reformatting and would avoid consuming
inordinate litigation resources? Or what if one assumes that the courts or
Congress could fashion a standard that approaches more closely he ideal
standard than do my examples? Could one then expect to employ such an
eligibility restriction as a sustainable agriculture policy tool?
The question is fundamental. A full response cannot yet be given based on
the current level of understanding of the economics of intellectual property
protection in the plant biotechnology sector. Theoretical and empirical studies
that are beginning to appear-predominantly in the agricultural economics
literature4 '-will assist in answering the question.
In evaluating such studies, policymakers-whether or not they count
themselves among the proponents of sustainable agriculture-must bear in mind
the complex interplay between utility patent protection and other forms of
protection for plants. Specifically, policymakers must reject analyses that are
based on the assumption that by ejecting plants from the utility patent regime
(e.g., through a subject matter eligibility restriction), one would direct plant
innovation into the public domain, where it will be accessible by all, free of any
license fees. Such analyses would exaggerate the social cost of utility patent
protection, and thus would exaggerate the social benefit of restricting utility patent
protection. Innovators in the plant breeding industry (like innovators generally)
will not abandon their innovations to the public as a result of utility patent
protection being withdrawn. Instead, innovators will redirect their efforts
towards acquiring other forms of protection.
In the plant area, there are a number of additional protection options that are
less attractive (from the innovator's perspective) than utility patent protection, but
41. Selected examples include Bonwoo Koo & Brian D. Wright, Dynamic Implications of Alternative
Intellectual Property Rights for Crop Genetic Resources (June 24, 1999) (on file with Koo, koo@axeklylu);
THE BIOTECHNOLOGY REVOLUTION IN GLOBAL AGRICULTURE: INVENTION, INNOVATION, AND INVESnRENTIN
THE CANOLA SECTOR (Peter W.B. Phillips & G.G. Khachatourians eds., 2001).
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more attractive than simply dedicating the innovation to the public domain: for
example, plant variety protection,42 trade secret protection,43 and, for some types
of plant innovation, plant patent protection.4 Moreover, plant breeders may seek
protections that do not depend on the intellectual property statutes at all-for
example, through the use of genetic use restriction technologies, which may
confer sterility or incorporate other genetic mechanisms for controlling
expression of various agronomic traits.4 5
Accordingly, it is simplistic -grossly so-to make policy based on the
assumption that by restricting utility patent eligibility, one diverts innovation into
the public domain. Instead, the more probable outcome of even an "idear patent
eligibility restriction in the plant area would be to divert innovation into other
intellectual property (or non-intellectual property) protection regimes. To the
extent that these alternative forms of protection are less desirable from a social
standpoint than utility patent protection,4 6 the diversion of innovation away from
the utility patent system represents a social cost that must be weighed in the
balance when policymakers compare the costs and benefits of patent eligibility
42. See infra notes 69-92 and accompanying text for a discussion.
43. For the leading decision on trade secret protection for plant genetic information, see Pioneer Hi-Bil niflv.
Holden Foundation Seeds, Inc., 35 F.3d 1226 (8th Cir. 1994) (decided under Iowa state trade secret law). The
patent statute (a federal statute) does not preempt state law trade secret regimes. See aslo Kewanee Oil Co. v.
Bicron Corp., 416 U.S. 470 (1974).
44. "Plant patent" protection under U.S. law applies to distinct and new plant varieties that have been asexually
reproduced. See 35 U.S.C. §§ 161-62 (1994) (setting forth the relevant patentability prerequisites); 35 U.S.C. §
163 (1994 & Supp. V 1999) (establishing that the plant patent owner obtains the "right to exclude others from
asexually reproducing the plant, and from using, offering for sale, or selling the plant so reproduced, or any of its
parts, throughout the United States, or from importing the plant so reproduced, or any parts thereof, into the United
States"); see also Imazio Nursery, Inc. v. Dania Greenhouses, 69 F.3d 1560 (Fed. Cir. 1995) (infringement only
occurs by actual taking of shoots from the protected plant). The architects of the plant patent regime did not expect
it to provide any significant source of intellectual property protection for grain crops. See Cary Fowler, TheP/aui
Patent Act of 1930: A Sociological History of its Creation, 82 J. PAT. & TRADEMARK OFF. SOC' Y 621 (2000).
Experience with the plant patent statute has bome out those predictions.
45. See ROYAL SOC' Y OF LONDON ET AL., supra note 8, at 32-34. Hybridization is, in effect, another form of
"technological" protection for plant innovation because hybrids do not breed true. See Blair, supra not 7, at305-
06 for a brief account.
46. Consider, for example, the disclosure of detailed technical teachings. The utility patent regime includes
rigorous disclosure requirements and from this standpoint may be more socially desirable than either plant variety
protection or trade secret protection, under which technical teachings may (or, in the case of trade secrets, must)
remain undisclosed and unavailable for follow-on innovators.
Similar comparisons can be made between utility patent protection and genetic antireplication measures.
The latter have social and economic consequences extending far beyond the bounds of the innovation arena. Patent
protection may look quite benign when compared to genetic use restriction technologies.
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restrictions.4 7 At all events, policymakers should refuse to accept any analysis
that inflates the social cost of patent protection by assuming that free access is
the inevitable outcome of restricting patent eligibility.
II. PLANT INNOVATION AND RESTRICTIONS ON PATENT SCOPE:
EXPERIMENTAL USE AS AN EXAMPLE
Whereas the doctrine of patent eligibility is a demonstrably ineffective
instrument for shaping the scope of patent protection, many other doctrines are
likely to serve better in fine-tuning the patent system in conformity with the
principles of sustainable agriculture. Among the candidates are the disclosure
requirements, 48 the obviousness doctrine, 49 and the doctrine of equivalents. 50
Another, less prominent doctrine may present some intriguing possibilities in the
area of utility patents for plants: the experimental use exception.
The experimental use exception excuses infringement liability for acts that are
carried out for purposes of experimentation. The exception might be brought to
bear on patented plant innovation in a number of ways. For example, a generic
experimental use exception (i.e., one cutting across all areas of patented
technology) might be applied, either as a matter of common law, or as matter of
hypothetical new legislation. Alternatively, one could envision an experimental use
exception that is specific to plant innovation, implemented judicially or
legislatively.
The experimental use doctrine has long been the darling of scholars. 5' Unlike
patent eligibility rules, the experimental use exception has great potential--in
47. 1 have not discussed other obvious social costs of restricting patent protection for plants, such as the
reduction in private investment in plant innovation. Empirical studies are needed so that an assessment of the
magnitude of the reduction can be made.
48. The process has already begun to occur. See Enzo Biochem, Inc. v. Calgene, Inc., 188 F.3d 1362 (Fed.
Cir. 1999) (concluding that claims to antisense technology violated the enablement requirement).
49. 35 U.S.C. § 103 (1994 & Supp. V 1999).
50. See infra note 84 for a brief discussion.
51. See, e.g., Richard E. Bee, Experimental Use as an Act of Patent Infringement, 39 J. PAT. OFF. SOCY 357
(1957). For more recent treatments, see Janice M. Mueller, No "Dilettante Affair": Rethinking the Experimental
Use Exception to Patent Infringement for Biomedical Research Tools, 76 WASH. L. REV. 1 (2001); Maureen A.
O'Rourke, Toward A Doctrine of Fair Use in Patent Law, 100 COLUM. L. REV. 1177 (2000); Suzanne T.
Michel, Note, The Experimental Use Exception to Infringement Applied to Federally Funded Inventions, 7 HIM
TECH. L.J. 369 (1992); Jordan P. Karp, Note, Experimental Use as Patent Infringement: The Impropriety of a
Broad Exception, 100 YALE L.J. 2169 (1991); Steven J. Grossman, Note, Experimental Use or Fair Use as a
Defense to Patent Infringement, 30 IDEA 243 (1990); Rebecca S. Eisenberg, Patents and the Progress ofScience:
Exclusive Rights and Experimental Use, 56 U. CHI. L. REV. 1017 (1989); Ronald D. Hantman, ExernaenaUse
as an Exception to Patent Infringement, 67 J. PAT. & TRADEMARK OFF. Soc'Y 617 (1985).
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theory-to effectuate important policy reforms, because it is a relatively direct
mechanism for fine-tuning patent scope. Indeed, a notion of liability-free
experimentation is intuitively appealing because it seems consonant with one of
the core aspirations of the patent system-to promote the progress of the useful
arts by making innovative technical teachings available to the public in the form of
the patent's written description (augmented by a deposit of biological subject
matter), so that the public can apply the teachings to the development of yet
further innovation. No doubt scholars have been attracted to the experimental use
doctrine both for its apparent theoretical centrality and for its potential
significance for patent policy.
However, as I detail in the following sections, policymakers would do well to
approach the doctrine of experimental use with carefully tempered enthusiasm.
Neither generic nor plant-specific experimental use rules are likely to serve as
effective policy tools if approached through traditional judicial or legislative
mechanisms. If the experimental use doctrine is to fulfill its considerable potential
as a policy tool, more creative approaches may be required.
A. Drawbacks of Generic Experimental Use Rules
U.S. patent law includes a common law experimental use exception. It is a
generic rule of allowable experimentation-that is, it might be applied to plant
breeding just as it might be applied to any other area of technical endeavor. It is
unlikely, however, that the generic experimental use exception, in either a
common law or a legislative manifestation, will emerge as a major force in
shaping the scope of patented plant innovation.
1. Frailty of Patent Law's Common Law Experimental Use Doctrine
The common law experimental use exception in U.S. patent law traces back
to dicta in two decisions by Justice Story. In Whittemore v. Cutter, Story
observed that where a patent owner asserted infringement of a patented machine,
"it could never have been the intention of the legislature to punish a man who
constructed such a machine merely for philosophical experiment. ... ,,2 In
Sawin v. Guild, Story seemed to articulate a two-pronged exception: use of a
patented invention "for the mere purpose of philosophical experiment, or to
52. Whittemore v. Cutter, (No. 17,600) 29 Fed. Cas. 1120, 1121 (C.C.D.Mass. 1813).
[Vol. 9.91
PATENT RIGHTS AND PLANT INNOVATION
ascertain the verity and exactness of the specification" was exempt from
infringement.
53
Notwithstanding its long history and the abundance of scholarly attention that
it has attracted, the common law experimental use exception has had almost no
impact in actual litigated cases. Three conventional explanations deserve
consideration. First, some cases in which an alleged infringement is arguably
"experimental" involve only minimal recoverable value for the patent owner, and
hence are not likely to be litigated to judgment.54 Second, it may be impossible
for courts to disentangle an alleged infringer's commercial motives from his
"philosophical" experimental motives. Thus, an unrefined experimental use test
along the lines of the Story formulation may constitute an empty gesture on the
part of infringement defendants.
Third, the Federal Circuit has approached the experimental use exception
restrictively. In Roche,55 the court explained that the philosophical
experimentation prong of the experimental use exception is "truly narrow" and
applies only where the experimentation is "for amusement, to satisfy idle
curiosity, or for strictly philosophical inquiry. 5 6 Under the Federal Circuit's
"truly narrow" approach, the experimental use doctrine does not "allow a violation
of the patent laws in the guise of 'scientific inquiry,' when that inquiry has
definite, cognizable, and not insubstantial commercial purposes. ' 7
The Federal Circuit's decision in Embrex provides an interesting recent
exposition of the doctrine.58 Defendant Service Engineering had retained a
university professor to run tests for the purpose of designing around Embrex's
patented method for immunizing chicken embryos in ovo (i.e., in the egg).5 9
Embrex asserted patent infringement and won a jury verdict, despite Service's
claim of experimental use. On appeal, the Federal Circuit affirmed the judgment
as a matter of law.60  The majority opinion treated Service's commercial
53. Sawin v. Guild, (No. 12,391) 21 Fed. Cas. 554, 555 (C.C.D.Mass. 1813).
54. By "minimal recoverable value," I mean that recoverable damages for past infringement are low, and the
value of an injunction against future infringement is also low.
55. Roche Prod., Inc. v. Bolar Pharmaceutical Co., 733 F.2d 858 (1984), cert. denied, 469 U.S. 856 (1984).
56. Id at 863.
57. Id. (refusing to extend the common law experimental use exception to insulate from infringement the testing
of a patented composition in connection with obtaining Food and Drug Administration (FDA) approval to market a
generic after patent expiration). The case precipitated the passage of a limited statutory experimental use exception,
35 U.S.C. § 271(e). See also infra note 93 and accompanying text.
58. Embrex, Inc. v. Service Engineering Corp., 216 F.3d 1343 (Fed. Cir. 2000).
59. Id. at 1346.
60. The Federal Circuit vacated and remanded as to the determination of damages. Id. at 1350-51.
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motivation as a matter free from any real doubt and, with little additional analysis,
found the experimental use assertion lacking.
Judge Rader filed a noteworthy concurring opinion. In Judge Rader' s view,
the patent law should recognize neither a de minimis defense to infringement nor
an experimental use exception. 61 As to the latter, Judge Rader took the view that
the Supreme Court's pronouncements in Warner-Jenkinson62-that intent is not
an element of infringement-precluded the court from recognizing an intent-based
experimental use exception.63 Judge Rader indicated that, in the alternative, if he
were forced to recognize the experimental use exception, he would do so only
most grudgingly: "even if the experimental use excuse retains some lingering
vitality, the slightest commercial implication will render the 'philosophical
inquiry/experimental use' doctrine inapplicable.... 64
There may be an additional explanation beyond the three offered so far for the
relative frailty of the common law experimental use doctrine. It may simply be
too difficult to articulate a satisfactory generic experimental use rule. That is,
perhaps the main lesson to be drawn from the undistinguished history of the
generic experimental use exception is not that experimental use is a flawed
principle, but that the scope of allowable experimental use is likely to vary greatly
depending upon the nature of the patented invention and the nature of the
technical field. Scholars and policymakers who advocate a more robust
experimental use doctrine might do well to consider how to flesh out the doctrine
within a particular technological context.
61. Concerning a de minimis defense-which is often intertwined with an experimental use defense-Judge
Rader pointed out that de minimis infringement should still constitute infringement but will only give rise to dk
minimis damages for past infringement. Id. at 1352-53 (Rader, J., concurring). This argument may underestimate
the economic consequences of an infringement determination. While damages for past infringement may be
minimal, the economic power of an injunction against future infringement may be substantial.
62. Wamer-Jenkinson Co., Inc. v. Hilton Davis Chem. Co., 520 U.S. 17 (1997).
63. Embrex Inc., 216 F.3d at 1352-53 (Rader, J., concurring). Judge Rader has an interesting point, but has
taken the argument a step further than I would go. Judge Rader seems to be arguing that, because the Supreme
Court specifically rejected the argument that proof of the alleged infringer's intent to copy should be an element of
the patent owner's infringement case, it must also have rejected the argument that an alleged infiringer may asst an
affirmative defense built around the alleged infringer's intent to experiment. I am attracted to a less ambitious
argument: that the recognition of an intent-based affirmative defense may create a serious tension with the strict
liability infringement regime, especially if the intent-based defense is so amorphous that it may be widely applied.
64. Id. at 1353 (citing Roche, 733 F.2d at 863).
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2. Legislating a Generic Form of Experimental Use
The recent legislative record concerning experimental use may reinforce the
point that a generic rule on experimental use is destined to remain of very limited
utility. In 1990, Congress considered adding a section 2710) to the patent statute,
which would have provided that:
[I]t shall not be an act of infringement to make or use a patented
invention solely for research and experimentation purposes
unless the patented invention has a primary purpose of research
or experimentation. . . . [I]f the patented invention has a
primary purpose of research or experimentation, it shall not be
an act of infringement to manufacture or use such invention to
study, evaluate, or characterize such invention or to create a
product outside the scope of the patent covering such invention
[to which subsection (e)(1) applies].65
There is little reason to expect that the proposed legislation would have had
any greater impact than the existing common law doctrine, given the probable
difficulty of establishing that one's making or using is "solely" for research or
experimentation purposes, as well as the lack of any detailed standard for
determining which activities are experimental.66 There is also no strong reason to
suggest that such legislation could pass today in any event.67
65. PATENT COMPETITIVENESS AND TECHNOLOGICAL INNOVATION ACT OF 1990, H.R. DOC. No. 101-9K0at
55-56 (2d Sess. 1990).
66. The legislative history did supply examples of activity that would have been shielded by such a rule:
(1) testing an invention to determine its sufficiency or to compare it to prior art; (2) tests to
determine how the patented invention works; (3) experimentation on a patented invention
for the purpose of improving on it or developing a further patentable invention; (4)
experimentation for the purpose of "designing around" a patented invention; (5) testing to
determine whether the invention meets the tester's purposes in anticipation of requesting a
license; and (6) academic instructional experimentation with the invention.
Id. at 44-45. These examples do go beyond restatement of the general principle of experimental use; however, it
may be significant for future legislative efforts that the more detailed enunciation of the standard was relegated to the
legislative history.
67. The proposed § 2710) was reported favorably out of committee. See Michel, supra note 51, at 388-89.
However, the legislation was never enacted.
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B. Plant-specific Experimental Use Rules: Drawbacks of Conventional
Judicial and Legislative Approaches
Only rarely have scholars considered the possibility of crafting experimental
use standards that are specifically tailored to discrete technological sectors.68 The
issue may well arise in the area of plant innovation, however, because courts (or
Congress) may be tempted to borrow experimental use concepts from the Plant
Variety Protection Act (PVPA) and use them to formulate a plant-specific
experimental use rule for patented plant innovation. The following sections
explain why proponents of sustainable agriculture should be skeptical of such an
approach.
1. Impropriety of Engrafting the PVPA Experimental Use Provision onto
Utility Patent Law
If experimental use is of interest as a policy tool for sustainable agriculture,
but the common law experimental use exception in utility patent law is not a
satisfactory vehicle, judges and policymakers might be tempted to look outside
the utility patent regime to the PVPA,6 9 which contains an express statutory
experimental use (or "research") exception.70 Some will undoubtedly argue that if
utility patent protection and PVPA protection coexist for plants, the experimental
use exception from the PVPA should be engrafted onto the utility patent regime,
to the extent that the utility patent regime encompasses plants.
Judges should resist such an argument. While the utility patent regime and
the PVPA overlap in their subject matter, they strike very different public/private
bargains. 71 The PVPA requires relatively low-quality disclosure as compared to
68. But see Julie E. Cohen & Mark A. Lemley, Patent Scope and Innovation in the Software bxinvy 89 CAL
L. REV. 1, 29 (2001) (exploring reverse engineering and experimentation defenses in the software patent context);
Irving N. Feit, Biotechnology Research and the Experimental Use Exception to Patent Infringement, 71 J. PAT.
TRADEMARK OFF. Soc'y 819 (1989).
69. 7 U.S.C. §§ 2321-2583 (1994). There is no indication in the legislative history of the PVPA that Congress
anticipated that plant innovation would find its way into the utility patent regime (nor is there any evidence
indicating whether Congress would have objected to it). Accordingly, the legislative record appears to be silent on
the question of whether Congress would have expected PVPA experimental use notions to be superimposed onto
the patent regime for patented plant innovation.
70. 7 U.S.C. § 2544.
71. 1 cannot offer a full discussion of the issue of overlapping intellectual property regimes in general, or even c"
the overlap between patent and plant variety regimes, within the space of this essay. The overlap issue manifests
itself in many intellectual property contexts. For one recent example, see Traffix Devices, Inc. v. Marketing
Displays, Inc., 532 U.S. 23 (2001), which discusses the functionality doctrine in the law of trade dress, implicating
the patent/trademark overlap.
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the utility patent regime, and in exchange confers relatively low-level protection as
compared to the utility patent regime. Simply transposing the experimental use
provision from one regime to the other would ignore these differences.
The differences are apparent on the face of the respective statutes. 72 The
utility patent regime requires disclosures that comply with the utility,73
enablement, 74 and written description requirements, 75 among others. In addition,
the utility patent regime requires not only that the claimed invention be new (in the
sense of being distinct from the statutorily-defined universe of prior art),76 but
also that it be non-obvious.77
By contrast, the PVPA does not require applicants to provide a enabling
disclosure and includes no comparable written description requirement.78
While the U.S. literature on the patent/plant variety overlap is underdeveloped, the issue has been given a
fuller airing in Europe. Examples of studies concluding that both types of protection may reasonably be extended
include Rainer Moufang, Protection for Plant Breeding and Plant Varieties: a Frontier of Patent Law, 23 INT'L
REV. INDUS. PROP. & COPYRT. 328 (1992) (criticizing the article 53(b) exclusion); Joseph Straus, Patent
Protection for New Varieties of Plants Produced by Genetic Engineering-Should "Double Protection " be
Prohibited?, 15 INT'L REV. INDUS. PROP. & COPYRT. 426 (1984) (criticizing the notion that patent protection and
plant variety protection together constitute "double protection").
72. In Pioneer, the Supreme Court briefly compared the two regimes. Pioneer, 2001 WL 156870, at *1011.
Beyond this comparison, however, the case law and legislative history provide little assistance on the question of
how the utility patent and PVPA regimes interrelate.
73. 35 U.S.C. § 101 (1994) (requiring that inventions be "useful" in order to qualify for patent protection).
74. 35 U.S.C. § 112.
The specification shall contain a written description of the invention, and of the manner
and process of making and using it, in such full, clear, concise, and exact terms as to
enable any person skilled in the art to which it pertains, or with which it is most nearly
connected, to make and use the same....
Id.
75. Courts have cited the "written description" language in 35 U.S.C. § 112 to justify a separate written
description requirement. The requirement has been applied with particular vigor to biotechnology inventions. Sw
Regents of the Univ. of California v. Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. Cir. 1997); Janice M. Mueller,
The Evolving Application of the Written Description Requirement to Biotechnological Inventions, 13 BEumE
TEcH. L.J. 615 (1998). For a general criticism, see Mark D. Janis, On Courts Herding Cats: Contending with
the "Written Description " Requirement (and Other Unruly Patent Disclosure Doctrines), 2 WASH. U. J.L. &
POL'Y. 55 (2000). Patent owners claiming biotechnology inventions routinely deposit samples in publicly
accessible depositories in order to facilitate compliance with the written description requirement. See37 C.FR. §§
1.801-809 (2000) (governing deposits of biological material).
76. See 35 U.S.C. § 102 (1994 & Supp. V 1999) (defining the categories of prior art).
77. 35 U.S.C. § 103(a) (1994 & Supp. V 1999).
A patent may not be obtained though the invention is not identically disclosed or
described as set forth in section 102 of this title, if the differences between the subject
matter sought to be patented and the prior art are such that the subject matter as a whole
would have been obvious at the time the invention was made to a person having ordinary
skill in the art to which said subject matter pertains.
Id.
78. For example, although the PVPA requires applicants to deposit seed, this requirement is not analogous to
utility patent law's written description requirement because the PVPA deposit need not be made to a publicly
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Similarly, while the PVPA requires varieties to be new, distinct, uniform, and
stable, 79 the PVPA includes no non-obviousness requirement. In sum, the PVPA
asks far less of applicants than does the utility patent regime.
The PVPA also gives far less protection. Analyzed superficially, the PVPA
may appear to confer significant rights; the principal PVPA infringement provision
contains language comparable to that of the principal utility patent infringement
provision.8" However, the distinctions between the two regimes far outweigh the
similarities.
First, and fundamentally, PVPA protection is protection for a specific
variety-i.e., a "plant grouping within a single botanical taxon of the lowest
known rank... ,81 This is exceedingly narrow protection-analogous, for
example, to limiting the copyright in a novel to the lowest level of abstraction, the
entirety of the literal text, word for word. 82 The legislative history reveals that the
copyright analogy is especially apt. Congress clearly assumed that the routine
accessible depository. 7 U.S.C. § 2422(4) (1994); 7 C.F.R. § 97.6(d)(1) (2001) (requiring that "[t]he applicant
shall submit with the application... at least 2,500 seeds of the viable basic seed required to reproduce the variety"
but including no requirement that the deposit be accessible to the public).
79. See 7 U.S.C. § 2402(a)(1) (1994 & Supp. V 1999) (establishing the standard for "new" varieties in
language reminiscent of statutory bar provisions from utility patent law); § 2402(a)(2) (1994) (establishing the
standard for distinctness: the variety is "clearly distinguishable from any other variety the existence of which is
publicly known or a matter of common knowledge at the time of the filing of the application"); § 2402(a)(3) (1994)
(establishing the standard for uniformity: "any variations are describable, ledictable, and commercially
acceptable"); § 2402(a)(4) (1994) (establishing the standard for stability: "the variety, when reproduced, will
remain unchanged with regard to the essential and distinctive characteristics of the variety with a reasonable degre
of reliability commensurate with that of varieties of the same category in which the same breeding method is
employed").
80. For the principal PVPA infiringement provision, see 7 U.S.C. § 2541(a) (1994 & Supp. V 1999), specifying
that infringing acts include, e.g., selling or offering to sell (§ 2541(a)(1) (1994)), importing (§ 2541(a)(2) (1994)),
sexually multiplying (§ 2541(a)(3) (1994)), and using (§ 2541(a)(4) (1994)). Cf 35 U.S.C. § 271(a) (1994 &
Supp. V 1999) (specifying that infringement of a utility, patent occurs in cases of unauthorized selling, offering to
sell, making, or using of a patented invention).
81. 7 U.S.C. § 2401(a)(9) (1994) defines "variety" as follows:
The term 'variety' means a plant grouping within a single botanical taxon of the lowest
known rank, that, without regard to whether the conditions for plant variety protection are
fully met, can be defined by the expression of the characteristics resulting from a given
genotype or combination of genotypes, distinguished from any other plant grouping by the
expression of at least one characteristic and considered as a unit with regard to the
suitability of the plant grouping for being propagated unchanged. A variety may be
represented by seed, transplants, plants, tubers, tissue culture plantlets, and other matter.
Because PVPA protection is limited to variety protection, innovative plant biotechnology processes cannot be
protected under the PVPA. Some observers see this as a serious gap in protection. See, e.g., Geertrui van
Overwalle, Patent Protectionfor Plants: A Comparison of American and European Approaches, 39 IDEAJ.L&
TEcH. 143, 166-68 (1999) (asserting that the failure of plant variety regimes to protect processes is a major
indication of the need to extend utility patent protection to plant innovation).
82. For a discussion of the notion of "levels of abstraction" in the law of copyright infringement, see Caciptxi
Associates Int'l v. Altai, Inc., 982 F.2d 693, 706-07 (2d Cir. 1992).
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form of PVPA infringement would be acts of intentional unauthorized
reproduction of protected varieties-i.e., straightforward copying. 83 This regime
stands in contrast to the utility patent scheme, which features a strict liability
infringement regime and allows peripheral claiming rather than limiting inventors
to specific preferred embodiments.8 4
Second, the PVPA contains a multiplicity of additional limitations on, and
exemptions from, protectable scope, most of which have no counterparts in
utility patent law. One of these, of course, is the experimental use exemption:
"The use and reproduction of a protected variety for plant breeding or other bona
fide research shall not constitute an infringement of the protection provided under
this Act."' 85 But the experimental use exemption exists alongside several other
83. Explaining the provision in 7 U.S.C. § 2541(a), which establishes that infringement of a protected variety
can occur prior to the issuance of a PVPA certificate where the protected variety is distributed with appropriate
notice, the legislative history states that this infringement provision "more resembles copyright law than patent
law. Justification for this may be found partly in the fact that infringement is expected almost never to be by
independent work, but by willful reproduction starting from the protected variety itself." CONG. REP.'. 91-1604,
at 11 (1970).
84. See supra notes 17-18 and accompanying text for an explanation of claiming practices in the utility patent
regime. The doctrine of equivalents in utility patent law provides another point of contrast with PVPA law. In
utility patent law, an accused device that avoids the literal reach of the claim terms avoids literal infringement, but
may still infringe if shown to incorporate equivalent elements. Wamer-Jenkinson Co. v. Hilton Davis Chem. Co,
520 U.S. 17, 40 (1997) (rejecting challenges to the existence of the doctrine of equivalents and concluding that
"[t]oday we adhere to the doctrine of equivalents").
The PVPA includes no direct analog to the doctrine of equivalents, although it does include a concept of
"essentially derived" varieties, which is likely to operate as a very cramped form of equivalency. PVPA
infringement provisions apply equally to "(1) any variety that is essentially derived from a protected variety, unless
the protected variety is an essentially derived variety; (2) any variety that is not clearly distinguishable from a
protected variety .. ." 7 U.S.C. § 2541(c) (1994).
The PVPA defines "essentially derived variety" in some detail:
(A) In General.- The term 'essentially derived variety' means a variety that-
(i) is predominantly derived from another variety (referred to in this paragraph as
the 'initial variety') or from a variety that is predominantly derived from the
initial variety, while retaining the expression of the essential characteristics
that result from the genotype or combination of genotypes of the initial
variety;
(ii) is clearly distinguishable from the initial variety; and
(iii) except for differences that result from the act of derivation, conforms to the
initial variety in the expression ofthe essential characteristics that result from
the genotype or combination of genotypes of the initial variety.
(B) Methods.- An essentially derived variety may be obtained by the selection of a
natural or induced mutant or of a somaclonal variant, the selection of a variant
individual from plants of the initial variety, backcrossing, transformation by genetic
engineering, or other method.
Id.
85. 7 U.S.C. § 2544 (1994).
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exemptions and limitations.86 For example, the PVPA contains a separate private
use provision,8 7 a "saved red" provision," and a potentially wide-ranging
compulsory licensing provision. 9 Moreover, the section 2541(a) proscription
86. Collectively, these provisions implement international obligations under the International Convention for
the Protection of New Varieties of Plants (as revised at Geneva on Mar. 19, 1991) (UPOV Publication No. 2221(E))
[hereinafter UPOV]. For example, article 15 of the 1991 text of UPOV establishes the following exceptions to the
breeder's right:
(1) [Compulsory exceptions] The breeder's right shall not extend to
(i) acts done privately and for non-commercial purposes,
(ii) acts done for experimental purposes and
(iii) acts done for the purpose of breeding other varieties, and, except where the
provisions cf Article 14(5) apply, acts referred to in Article 14(1) to (4) in
respect of such other varieties.
(2) [Optional exception] Notwithstanding Article 14, each Contracting Party may,
within reasonable limits and subject to the safeguarding of the legitimate inteosef
the breeder, restrict the breeder's right in relation to any variety in order to permit
farmers to use for propagating purposes, on their own holdings, the product of the
harvest which they have obtained by planting, on their own holdings, the prtrccai
variety or a variety covered by Article 14(5)(a)(i) or (ii).
Id. art. 15.
87. 7 U.S.C. § 2541(e) (1994) ("It shall not be an infringement of the rights of the owner of the variety to
perform any act done privately and for noncommercial purposes.").
88. 7 U.S.C. § 2543 (1994) provides that:
Except to the extent that such action may constitute an infringement under subsections (3)
and (4) of section 2541 of this title, it shall not infringe any right hereunder for a person to
save seed produced by the person from seed obtained, or descended from seed obtained, by
authority of the owner of the variety for seeding purposes and use such saved seed in the
production of a crop for use on the farm of the person, or for sale as provided in this
section. A bona fide sale for other than reproductive purposes, made in channels usual for
such other purposes, of seed produced on a farm either from seed obtained by authority of
the owner for seeding purposes or from seed produced by descent on such farm from seed
obtained by authority of the owner for seeding purposes shall not constitute an
infringement....
For litigation on the predecessor version of the saved seed exemption, see Asgrow Seed Co. v. Winterboer, 513
U.S. 179 (1995).
89. 7 U.S.C. § 2404 (1994) provides a public-interest driven compulsory license:
The Secretary may declare a protected variety open to use on a basis of equitable
remuneration to the owner, not less than a reasonable royalty, when the Secretary
determines that such declaration is necessary in order to insure an adequate supply of fiber,
food, or feed in this country and that the owner is unwilling or unable to supply the public
needs for the variety at a price which may reasonably be deemed fair. Such declaration may
be, with or without limitation, with or without designation of what the remuneration is to
be; and shall be subject to review as under section 2461 or 2462 of this title (any finding
that the price is not reasonable being reviewable), and shall remain in effect not more than
two years. In the event litigation is required to collect such remuneration, a higher rate
may be allowed by the court.
Under utility patent law, only in the rarest circumstances have courts, by way of declining injunctive relief,
effectively granted compulsory licenses based on general notions of the public interest. See, e.g., City of
Milwaukee v. Activated Sludge, Inc., 69 F.2d 577, 593 (7th Cir. 1934); see also TRIPS Agreement, suprarxt
16 (establishing limitations on compulsory licensing practices in national legislation).
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against unauthorized "use"90 extends only to unauthorized use in "producing"
another variety. Use in "developing" another variety, even if unauthorized, is not
infringement. 9'
In addition, attempting to inject the PVPA experimental use provision into the
utility patent regime is administratively more complex than it would appear on the
surface. A PVPA certificate includes no claims defining the scope of the grant;
the grant is monolithic, and the experimental use exception derogates from that
monolithic grant. By contrast, in the utility patent regime, individual claims define
the scope of the grant, and any experimental use exception derogates from
individual claims. Accordingly, a rule that the PVPA experimental use exception
applies to utility patents on plants leaves many questions unanswered. For
example, does the exception apply only to those claims directed to plants? Only
to claims directed to plant varieties? To entire patents that contain at least one
claim directed to plants or to plant varieties? The same questions about claiming
format that bedeviled a restrictive eligibility rule 92 would arise in this context as
well.
2. Plant-specific Legislation on Experimental Use: Issues ofAgreement
on Trade-Related Aspects of Intellectual Property Rights (TRIPS) Compliance
The fact that a judge should not borrow PVPA experimental use concepts and
inject them into the utility patent scheme does not end the analysis. Some might
argue that Congress should create a plant-specific experimental use provision.93
90. 7 U.S.C. § 2541(a).
91. The legislative history attempts to explain this exceedingly fine distinction and its relationship to the
experimental use provision:
Producing (as distinguished from developing) a hybrid or different variety meansto use of
the protected variety in producing the commercial class of seed of a variety constitutes
infringement. Use of the protected variety as one source of germ plasm to breed a novel
variety is permissible. As an example, the use of a protected inbred line of com to cross it
with another inbred line to produce a hybrid for commercial use, or production of a
composite variety which is repeatedly reconstituted for commercial sale by intercrossing a
set of seed lines one of which is protected, shall constitute an infringement. The use of
such inbred line for hybridization with other materials to develop through breeding a novel
inbred line as provided in section 114 [7 U.S.C. § 2544, the experimental use provision],
however, does not ronstitute infringement; nor does the production of such new inbred line
for the general market constitute infringement.
PLANT VARIETY PROTECTION ACT, H.R. REP. Doc. No. 91-1605, at 11 (1970).
92. See supra Part IIA.
93. Congress has already created a specialized experimental use provision to shield tests conducted "solely for
uses reasonably related to" obtaining FDA approval. 35 U.S.C. § 271(e) (1994 & Supp. V 1999). Section 271(e)
is an extraordinarily complex (some would say inelegant) component of a delicate legislative compromise and may
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One response to such a proposal derives from its international implications. A
plant-specific experimental use provision might draw charges that it violates
international obligations set out in the TRIPS Agreement. 94 Article 27(1) specifies
that patent rights must be "enjoyable without discrimination as to... the field of
technology .... 95 Article 28 provides that among the patent rights enjoyable are
the rights to prevent unconsented making or using, either of which could be
implicated by an experimentation exemption.
96
It is not clear how the TRIPS argument would be resolved for a plant-
specific experimental use exemption. Article 27(3)(b) allows members to exclude
plants from patent eligibility altogether if they enact a sui generis regime for plant
variety protection. Some may argue that if member states have the authority to
eliminate plants from the utility patent scheme altogether, they necessarily have
the lesser authority to place plant-specific limitations on the utility patent right.
Additional arguments may draw on article 30, under which members may provide
"limited exceptions to the exclusive rights conferred by a patent" under specified
conditions.97 The reach of article 30 is not currently clear. Similar questions
have surrounded the surgical methods exemption of 35 U.S.C. § 287(c).98
C. An Alternative Approach: Informal Breeders' Guidelines?
If conventional judicial and legislative approaches to various experimental use
rules are unlikely to yield satisfactory results, it may seem to follow that the
experimental use doctrine should be discarded as a serious candidate for balancing
private rights against public access in plant innovation. But before turning away
to more promising alternatives, policymakers might wish to consider whether a
not serve well as a model for other technology-specific experimental use provisions. See, e.g., Eli Lilly & Co. v.
Medtronic, Inc., 496 U.S. 661, 679 (1990) ("No interpretation we have been able to imagine can transform §
271(e)(1) into an elegant piece of statutory draftsmanship.").
94. See TRIPS Agreement, supra note 16.
95. Id.
96. Specifically, article 28(I)(a) of the TRIPS Agreement provides that "(1) A patent shall confer on its owner
the following exclusive rights: (a) where the subject matter of a patent is a product, to prevent third parties not
having the owner's consent from the acts of: making, using, offering for sale, selling, or importing for these
purposes that product .... " Id. at 94.
97. In particular, article 30 of the TRIPS Agreement provides that limited exceptions are allowable "provided
that such exceptions do not unreasonably conflict with a normal exploitation of the patent and do not unreasonably
prejudice the legitimate interests of the patent owner, taking account of the legitimate interests of third parties." Id
at 95.
98. See Cynthia M. Ho, Patents, Patients, and Public Policy: An Incomplete Intersection at 35 US. C §
287(c), 33 U.C. DAVIS L. REV. 601, 653-73 (2000).
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non-traditional approach to the experimental use question might be worth
pursuing.
The allowable scope of experimental use in a given technology sector may
turn out to be more a matter of industry custom than patent law doctrine. If that
is so, perhaps some thought should be given to articulating the relevant customs
in the plant breeding industry and recording them in the form of a set of informal
breeders' guidelines on the allowable use of patented plant inventions. It would be
interesting to consider whether, for example, the organized bar, acting with
industry and government participation, could arrive at a detailed statement of
research norms that would provide reasonable guidance to researchers without
seriously impairing the value of patent rights.
No doubt there are many objections to this proposal as well. Some may
question whether any set of circumstances could be imagined under which the
plant breeding industry would agree to participate in such an effort.99 Others, no
doubt, would scrutinize any agreed guidelines closely for evidence of
anticompetitive collusion.' 00 Still others may wonder whether the phenomenon of
patenting plant innovation is so new that customs are still evolving.
Nevertheless, even if discussions over the scope of allowable experimental
use in the plant breeding area failed to result in the drafting of specific guidelines,
it still may be a discussion worth having. At the very least, it could serve as the
beginning of a constructive dialogue that might hasten the emergence of
articulable norms to guide researchers in future plant biotechnology
experimentation. Proponents of sustainable agriculture who seek to make the
utility patent system more responsive to sustainable agriculture policy initiatives
should support such a dialogue.
99. On this point, it may well be that industry would rather participate in formulating the relevant standards
than have them imposed from without, as may be the case if the PVPA experimental use provision is engrafted onto
the patent statute.
100. Government participation in the formulation of any such guidelines would be important to insulate against
any such charges. In any event, it should not be difficult to distinguish between legitimate cooperation on the one
hand, and, on the other, a horizontal agreement among plant biotechnology firms suppressing competition. On the
latter issue, see generally HERBERT HOVENKAMP ET AL., IP AND ANTITRUST: AN ANALYSIS OF ANTITRUST
PRINCIPLES APPLIED TO INTELLECTUAL PROPERTY LAW (2002) (discussing horizontal restraints in intellectual
property licensing).
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